The undiagnosed chronically-infected HCV population in France. Implications for expanded testing recommendations in 2014.

by Cécile Brouard, Yann Le Strat, Christine Larsen, Marie Jauffret-Roustide, Florence Lot, Josiane Pillonel
Published 2015-01-01

Rapid and large-scale implementation of HCV treatment advances in France, 2007–2015

by Cécile Brouard, Marjorie Boussac-Zarebska, Christine Silvain, Julien Durand, Victor de Lédinghen, Josiane Pillonel, Elisabeth Delarocque-Astagneau
Published 2017-12-01

French hepatitis C care cascade: substantial impact of direct-acting antivirals, but the road to elimination is still long

by Cécile Brouard, Josiane Pillonel, Marjorie Boussac, Victor de Lédinghen, Antoine Rachas, Christine Silvain, Nathalie Lydié, Stéphane Chevaliez, Corinne Pioche, Julien Durand, Florence Lot, Elisabeth Delarocque-Astagneau
Published 2020-10-01

The French pill scare and the reshaping of social inequalities in access to medical contraceptives

by Mireille Le Guen, Mylène Rouzaud-Cornabas, Henri Panjo, Laurent Rigal, Virginie Ringa, Caroline Moreau, Arnaud Gautier, Nathalie Lydié, Delphine Rahib, Frédérike Limousi, Jean-Baptiste Richard, Cécile Brouard
Published 2020-08-01

HCV and HBV prevalence based on home blood self-sampling and screening history in the general population in 2016: contribution to the new French screening strategy

by Cécile Brouard, Leïla Saboni, Arnaud Gautier, Stéphane Chevaliez, Delphine Rahib, Jean-Baptiste Richard, Francis Barin, Christine Larsen, Cécile Sommen, Josiane Pillonel, Elisabeth Delarocque-Astagneau, Nathalie Lydié, Florence Lot, the 2016 Health Barometer Group
Published 2019-10-01